Hedge Fund - Redmile Group
Nurix Therapeutics Inc. (NRIX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $78,989,093 | 5.5% | 4,192,627 | $22.92 |
| 2 | 2024 - Q3 (2024-09-30) | $96,193,643 | 5.66% | 4,280,981 | $22.65 |
| 3 | 2024 - Q2 (2024-06-30) | $92,320,866 | 5.58% | 4,423,616 | $15.57 |
| 4 | 2024 - Q1 (2024-03-31) | $65,900,335 | 2.41% | 4,483,016 | $10.76 |
| 5 | 2023 - Q4 (2023-12-31) | $33,607,276 | 1.2% | 3,256,519 | $6.85 |
| 6 | 2023 - Q3 (2023-09-30) | $22,391,780 | 1.06% | 2,848,827 | $9.13 |
| 7 | 2023 - Q2 (2023-06-30) | $28,544,517 | 1.09% | 2,857,309 | $10.20 |
| 8 | 2023 - Q1 (2023-03-31) | $24,414,530 | 1.05% | 2,749,384 | $10.42 |
| 9 | 2022 - Q4 (2022-12-31) | $32,948,608 | 1.34% | 3,000,784 | $12.06 |
| 10 | 2022 - Q3 (2022-09-30) | $39,177,000 | 1.51% | 3,006,684 | $15.83 |
| 11 | 2022 - Q2 (2022-06-30) | $38,095,000 | 1.45% | 3,006,684 | $11.33 |
| 12 | 2022 - Q1 (2022-03-31) | $42,293,000 | 1.32% | 3,018,784 | $17.75 |
| 13 | 2021 - Q4 (2021-12-31) | $85,642,000 | 1.94% | 2,958,284 | $30.32 |
| 14 | 2021 - Q3 (2021-09-30) | $92,669,000 | 1.61% | 3,093,077 | $30.86 |
| 15 | 2021 - Q2 (2021-06-30) | $84,633,000 | 1.25% | 3,190,077 | $29.36 |
| 16 | 2021 - Q1 (2021-03-31) | $103,036,000 | 1.45% | 3,314,117 | $37.84 |
| 17 | 2020 - Q4 (2020-12-31) | $93,581,000 | 1.13% | 2,846,125 | $33.14 |
| 18 | 2020 - Q3 (2020-09-30) | $90,542,000 | 1.66% | 2,593,570 | $25.20 |
The displayed share prices are average quarterly stock market prices.